To determine whether the synergy observed was specific for SPT or might apply to other antimycobacterial agents, CPZ was applied as the anchor compound in combination assays with a panel of anti-TB antibiotics of different classes and mechanisms of action (see Table S2 in the supplemental material). This evidence concerns the gene CPZ and tuberculosis.